Raymond James Financial’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.8M Buy
495,996
+7,035
+1% +$177K ﹤0.01% 2165
2026
Q2
$14M Buy
488,961
+14,161
+3% +$449K ﹤0.01% 1854
2026
Q1
$14.9M Buy
474,800
+265,351
+127% +$8.36M ﹤0.01% 1684
2025
Q4
$6.17M Sell
209,449
-34,653
-14% -$963K ﹤0.01% 2343
2025
Q3
$6.16M Sell
244,102
-45,320
-16% -$1.1M ﹤0.01% 2320
2025
Q2
$6.95M Sell
289,422
-108,602
-27% -$2.52M ﹤0.01% 2149
2025
Q1
$9.11M Sell
398,024
-53,654
-12% -$1.29M ﹤0.01% 1877
2024
Q4
$11.4M Buy
+451,678
New +$11.4M ﹤0.01% 1739

Other funds holding RTO

Raymond James Financial's RTO Position: Q3 2026 in Review

Raymond James Financial increased its Rentokil (RTO) stake by 1.4% in Q3 2026, buying an estimated $177K and bringing the position to 495,996 shares worth $9.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Raymond James Financial first reported a position in RTO in Q4 2024 and has held it in 8 quarters since. The position peaked at $14.9M in Q1 2026. 258 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Raymond James Financial held 495,996 shares of Rentokil worth $9.8M as of Q3 2026.
  • Raymond James Financial bought 7,035 Rentokil shares in Q3 2026, an estimated $177K.
  • Rentokil made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2165 holding.
  • Raymond James Financial first reported a position in Rentokil in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Rentokil position peaked at $14.9M in Q1 2026.
  • 258 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.